Fresenius Medical Care AG (FMS) Form 6-K — May 28, 2026
Fresenius Medical Care AG launched the first tranche of a new share buyback program with a total volume of up to EUR 1 billion. The initial tranche, amounting to EUR 600 million, commenced on May 28, 2026, and is expected to be completed by December 15, 2026. The company authorized the repurchase of up to 29,341,344 shares, which will predominantly be cancelled to reduce share capital. This move complements the company’s dividend policy and reflects management’s commitment to disciplined, value-focused capital management.
Key figures
- Gross Proceeds
- EUR 1,000,000,000
- Shares Offered
- 29341344
- Program End Date
- May 27, 2027
- Max Treasury Shares
- 26856463
- First Tranche Amount
- EUR 600,000,000
- First Tranche End Date
- December 15, 2026
- Treasury Share Limit Percent
- 10
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.